"We are delighted to welcome Karen Ignagni to the Board of CTI," said James A. Bianco, M.D., President and CEO of CTI. "Karen's leadership, deep insight and ...
In The Wall Street Journal, Karen Ignagni writes that specialty drugs account for 25% of U.S. drug costs. Health plans need to know more about them.
Recommended offer:
Get a custom quote for your event:
Get StartedSpeaker Search is a marketplace of speakers designed for talent buyers. We do not represent or manage speakers; instead, we provide event planners with the most comprehensive resource to discover and book the right talent.